Financials
Income statement
Fiscal date | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
---|---|---|---|---|
Total reported revenue | 37.0B | 34.3B | 37.8B | 35.2B |
Cost of revenue | 7.5B | 7.8B | 7.7B | 8.0B |
Gross profit | 29.5B | 26.6B | 30.1B | 27.2B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 639.0M | 643.9M | 381.2M | 261.5M |
Other operating expenses | 10.1B | 9.3B | 11.4B | 8.0B |
Operating income | 11.0B | 16.6B | 14.1B | 11.7B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 558.8M | 116.4M | 88.5M | 79.8M |
Other income expense | — | — | — | — |
Pretax income | 11.8B | 17.3B | 14.7B | 12.2B |
Tax provision | 4.7B | 4.4B | 369.9M | 10.8B |
Net income | 7.2B | 12.9B | 14.3B | 1.4B |
Basic EPS | — | 133.8 | 3.9 | 3.9 |
Diluted EPS | — | 133.8 | 3.9 | 3.9 |
Basic average shares | — | 88.4M | 94.3M | 84.5M |
Diluted average shares | — | 88.4M | 94.3M | 84.5M |
EBITDA | 16.6B | 17.4B | 20.9B | 18.5B |
Net income from continuing op. | — | — | — | — |
Minority interests | -1.2B | -1.0B | -14.0B | -1.1B |
Preferred stock dividends | 0 | 0 | 0 | 0 |